When is coronary CT angiography indicated, and what are the preparation steps, contraindications, and follow‑up management?

Coronary CT Angiography: Indications, Preparation, Contraindications, and Follow-up

Primary Indication

Coronary CT angiography (CCTA) is recommended as the preferred initial diagnostic test for symptomatic patients with low to moderate (>5%–50%) pre-test likelihood of obstructive coronary artery disease (CAD) to rule out obstructive disease and estimate risk of major adverse cardiovascular events. 1

When CCTA is Indicated

Symptomatic Patients - Primary Scenarios

• Low to moderate pre-test probability (>5%–50%): CCTA is the Class I recommendation for ruling out obstructive CAD 1
• Equivocal or non-diagnostic functional testing: When stress tests are inconclusive or discrepant from clinical suspicion 2
• After non-diagnostic functional imaging: CCTA is recommended when other non-invasive tests fail to provide diagnostic clarity 1

Additional Accepted Indications

• Coronary bypass graft assessment: Evaluating patency and location of previous grafts 2
• Anomalous coronary arteries: Identifying and defining the course of congenital coronary anomalies 2
• Pre-cardiac surgery evaluation: Excluding CAD in low-risk patients before valve surgery 2
• Dilated cardiomyopathy: Ruling out CAD as etiology when cause is unknown 2
• Structural heart procedures: Pre-procedural planning for valve interventions and assessment of cardiac anatomy 3

Moderate to High Pre-test Probability (>15%–85%)

In this population, functional imaging (stress echo, SPECT, PET, or CMR) is generally preferred over CCTA 1. However, CCTA may be acceptable when:

• Functional imaging is non-diagnostic 1
• Patient refuses invasive angiography but results will influence therapeutic decisions 2

Contraindications

Absolute Contraindications

• Severe renal failure (eGFR <30 mL/min/1.73 m²) 1
• Pregnancy (radiation exposure) 2
• Severe contrast allergy 2

Relative Contraindications/Conditions Making Good Image Quality Unlikely

CCTA is not recommended in patients with 1:

• Decompensated heart failure
• Extensive coronary calcifications
• Fast irregular heart rate or uncontrolled rapid heart rate 2
• Frequent atrial or ventricular ectopy 2
• Severe obesity
• Inability to cooperate with breath-hold commands (15-20 seconds required) 2

Clinical Scenarios Where CCTA Should NOT Be Used

• Routine screening in asymptomatic patients 2
• High pre-test probability of CAD or high-risk acute coronary syndrome 2
• Known significant CAD (unless specific indication like graft assessment) 2
• Very low pre-test probability (≤5%): Deferral of further testing should be considered 1

Preparation Steps

Pre-Test Assessment

1. Calculate pre-test probability using Risk Factor-weighted Clinical Likelihood model 1
2. Assess renal function (eGFR) - essential before contrast administration 1
3. Evaluate heart rate and rhythm - sinus rhythm required, heart rate ideally <65 bpm 4, 5
4. Screen for contraindications to beta-blockers and nitrates 5

Pharmacological Preparation

Beta-blocker administration (typically metoprolol) 6, 5:

• Goal: Heart rate <65 beats per minute
• Contraindications: Hypotension, high-degree AV block, decompensated heart failure, severe asthma/COPD, vasospastic disease 5
• Alternative: Diltiazem (calcium channel blocker) for patients with asthma, bronchospastic disease, or heart transplant recipients 5

Sublingual nitroglycerin 6, 5:

• Purpose: Dilate coronary arteries to improve visualization
• Contraindications: Concurrent use of erectile dysfunction medications (phosphodiesterase-5 inhibitors), severe anemia, aortic stenosis, preload-dependent cardiac conditions 5

Patient Instructions

• Breath-hold capability: Must hold breath for 15-20 seconds 2
• Remain motionless during acquisition 2
• Hydration: Adequate hydration before and after contrast administration

Follow-up Management Based on CCTA Results

Negative CCTA (No Obstructive CAD)

• No further invasive testing required 1
• Continue guideline-directed medical therapy for risk factor modification
• Reassurance - high negative predictive value 2

Positive CCTA (Obstructive CAD Identified)

Functional imaging is recommended when CCTA shows CAD of uncertain functional significance 1. Options include:

• Stress echocardiography
• SPECT or PET myocardial perfusion imaging
• CMR perfusion imaging

Significant Stenosis Requiring Intervention

Invasive coronary angiography (ICA) with availability of functional assessment (FFR/iFR) is recommended 1:

• For severe symptoms refractory to medical therapy
• High event risk
• When revascularization is being considered

Non-Diagnostic CCTA

• Proceed to functional imaging for myocardial ischemia assessment 1
• Consider alternative imaging modality based on patient characteristics

Critical Pitfalls to Avoid

1. Extensive calcification: Severely limits diagnostic accuracy - consider functional imaging instead 1
2. Inadequate heart rate control: Results in motion artifacts and non-diagnostic studies 2, 6
3. Inappropriate patient selection: Using CCTA in high pre-test probability patients wastes resources and delays appropriate invasive evaluation 2
4. Ignoring renal function: Contrast-induced nephropathy risk in patients with eGFR <30 1
5. Medication interactions: Nitrates with PDE-5 inhibitors can cause severe hypotension 5
6. Overuse in asymptomatic screening: Not indicated and exposes patients to unnecessary radiation 2

Radiation Considerations

Modern CCTA protocols achieve radiation doses similar to or lower than invasive coronary angiography 4. However, radiation exposure remains a consideration, particularly in younger patients and women of childbearing age.